Merck & Co. , Inc. operates in the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Merck & Co. with three other
companies in this sector in the United States:
sales of $38.45 billion
of which 85%
of which 44%
was Operating Segment-Global Established Pha), and
of which 59%
Merck & Co. reported sales of $39.50 billion
December of 2015.
decrease of 6.5%
versus 2014, when the company's sales were $42.24 billion.
Contributing to the drop in overall sales was the 34.5% decline
in All Other, from $5.59 billion to $3.66 billion.
There were also decreases in sales in
Merck Pharmaceutical (down 3.5% to $34.78 billion)
However, these declines were partially offset by the increase in sales of
Unallocated (up 73.3% to $1.06 billion)